Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SGLT-2 Inhibitors”

392 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 392 results

Early research (Phase 1)Study completedNCT00963768
What this trial is testing

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 116
Not applicableStudy completedNCT06370247
What this trial is testing

First-time Usage of SGLT2 Inhibitors in Type 2 Diabetic Patients Who Are Fasting During Ramadan: Safety and Efficacy

Who this might be right for
SGLT2 Inhibitors, First Time UseType2 DiabetesFasting in Ramadan
Sohag University 60
Post-approval studies (Phase 4)WithdrawnNCT02768220
What this trial is testing

The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products

Who this might be right for
SGLT-2 InhibitorsAdvanced Glycation End ProductsDiabetes
Northwell Health
Large-scale testing (Phase 3)Not Yet RecruitingNCT07211802
What this trial is testing

CKM For Safe Use of SGLT2i in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes (T1D)
University of California, San Diego 52
Not applicableStudy completedNCT05795400
What this trial is testing

Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy

Who this might be right for
Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection FractionHeart Failure With Mid Range Ejection Fraction+1 more
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50
Large-scale testing (Phase 3)Study completedNCT07344922
What this trial is testing

SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia

Who this might be right for
Chronic Kidney DiseaseAnemiaCardiovascular Calcification
Mansoura University 100
Post-approval studies (Phase 4)Study completedNCT05621551
What this trial is testing

Dapagliflozin Therapy In Cardiac Surgery

Who this might be right for
Diabetes Mellitus, Type 2Cardiac Surgery
China National Center for Cardiovascular Diseases 178
Not applicableUnknownNCT05897489
What this trial is testing

SGLT2 for Heart Failure in CHD Patients

Who this might be right for
Heart Failure
Centre Hospitalier Universitaire de Nice 100
Post-approval studies (Phase 4)UnknownNCT02528019
What this trial is testing

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

Who this might be right for
Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
Kurume University 100
Not applicableStudy completedNCT02993614
What this trial is testing

Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors

Who this might be right for
Diabetes Mellitus Type 2
AstraZeneca 99,999
Not applicableUnknownNCT06251453
What this trial is testing

Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery

Who this might be right for
Atrial Fibrillation
Hamad Medical Corporation 3,280
Not applicableUnknownNCT06326528
What this trial is testing

SGLT2 Inhibitors and Perioperative Period

Who this might be right for
Perioperative Complication
Assiut University 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT07527390
What this trial is testing

CANagliflozin In DIALysis Patients

Who this might be right for
DialysisChronic Kidney Disease (Stages 4 and 5)
University Medical Center Groningen 10
Early research (Phase 1)Study completedNCT04450563
What this trial is testing

Low Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin System

Who this might be right for
Type 1 Diabetes
McGill University 25
Post-approval studies (Phase 4)Study completedNCT02397421
What this trial is testing

Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes

Who this might be right for
Heart FailureDiabetes
University of Dundee 56
Early research (Phase 1)Study completedNCT05266404
What this trial is testing

Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components

Who this might be right for
Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
AstraZeneca 46
Not applicableStudy completedNCT06000722
What this trial is testing

SGLT-i Use in Diabetic Foot Ulcer Disease

Who this might be right for
Diabetic Foot Ulcer
University of Leicester 21
Post-approval studies (Phase 4)UnknownNCT05225077
What this trial is testing

Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients

Who this might be right for
Renal Insufficiency, ChronicCardiac CatheterizationPercutaneous Coronary Intervention
Dong-A University 600
Post-approval studies (Phase 4)Study completedNCT03178591
What this trial is testing

Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor

Who this might be right for
Diabetes Mellitus, Type 2Ischemic Heart Disease
Chiang Mai University 43
Post-approval studies (Phase 4)Not Yet RecruitingNCT06858436
What this trial is testing

SGLT2 Inhibitor Utilization Re-perfusion Therapy

Who this might be right for
Acute Ischemic Stroke From Large Vessel Occlusion
Taichung Veterans General Hospital 150
Load More Results